Small Cell Lung Cancer Therapeutics Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Small Cell Lung Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Cell Lung Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Cell Lung Cancer Therapeutics Overall Market Size
2.1 Global Small Cell Lung Cancer Therapeutics Market Size: 2021 VS 2027
2.2 Global Small Cell Lung Cancer Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Cell Lung Cancer Therapeutics Players in Global Market
3.2 Top Global Small Cell Lung Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Small Cell Lung Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Small Cell Lung Cancer Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Small Cell Lung Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Cell Lung Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Small Cell Lung Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Cell Lung Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Small Cell Lung Cancer Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Biologics
4.1.3 Small Molecules
4.2 By Type - Global Small Cell Lung Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Small Cell Lung Cancer Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Small Cell Lung Cancer Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Small Cell Lung Cancer Therapeutics Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Small Cell Lung Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Small Cell Lung Cancer Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Small Cell Lung Cancer Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Small Cell Lung Cancer Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Small Cell Lung Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Small Cell Lung Cancer Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Small Cell Lung Cancer Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Small Cell Lung Cancer Therapeutics Revenue, 2016-2027
6.3.2 US Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.3.3 Canada Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.3.4 Mexico Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Small Cell Lung Cancer Therapeutics Revenue, 2016-2027
6.4.2 Germany Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4.3 France Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4.4 U.K. Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4.5 Italy Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4.6 Russia Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.4.8 Benelux Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Small Cell Lung Cancer Therapeutics Revenue, 2016-2027
6.5.2 China Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.5.3 Japan Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.5.4 South Korea Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.5.6 India Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Small Cell Lung Cancer Therapeutics Revenue, 2016-2027
6.6.2 Brazil Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.6.3 Argentina Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Small Cell Lung Cancer Therapeutics Revenue, 2016-2027
6.7.2 Turkey Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.7.3 Israel Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
6.7.5 UAE Small Cell Lung Cancer Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Sanofi
7.1.1 Sanofi Corporate Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Small Cell Lung Cancer Therapeutics Major Product Offerings
7.1.4 Sanofi Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.1.5 Sanofi Key News
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporate Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Small Cell Lung Cancer Therapeutics Major Product Offerings
7.2.4 Bristol-Myers Squibb Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.2.5 Bristol-Myers Squibb Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Small Cell Lung Cancer Therapeutics Major Product Offerings
7.3.4 GlaxoSmithKline Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.3.5 GlaxoSmithKline Key News
7.4 Menarini
7.4.1 Menarini Corporate Summary
7.4.2 Menarini Business Overview
7.4.3 Menarini Small Cell Lung Cancer Therapeutics Major Product Offerings
7.4.4 Menarini Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.4.5 Menarini Key News
7.5 Ziopharm Oncology
7.5.1 Ziopharm Oncology Corporate Summary
7.5.2 Ziopharm Oncology Business Overview
7.5.3 Ziopharm Oncology Small Cell Lung Cancer Therapeutics Major Product Offerings
7.5.4 Ziopharm Oncology Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.5.5 Ziopharm Oncology Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Small Cell Lung Cancer Therapeutics Major Product Offerings
7.6.4 Merck Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.6.5 Merck Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Small Cell Lung Cancer Therapeutics Major Product Offerings
7.4.4 Novartis Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.7.5 Novartis Key News
7.8 AstraZeneca
7.8.1 AstraZeneca Corporate Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Small Cell Lung Cancer Therapeutics Major Product Offerings
7.8.4 AstraZeneca Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.8.5 AstraZeneca Key News
7.9 Takeda Pharmaceutical
7.9.1 Takeda Pharmaceutical Corporate Summary
7.9.2 Takeda Pharmaceutical Business Overview
7.9.3 Takeda Pharmaceutical Small Cell Lung Cancer Therapeutics Major Product Offerings
7.9.4 Takeda Pharmaceutical Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.9.5 Takeda Pharmaceutical Key News
7.10 Teva Pharmaceutical
7.10.1 Teva Pharmaceutical Corporate Summary
7.10.2 Teva Pharmaceutical Business Overview
7.10.3 Teva Pharmaceutical Small Cell Lung Cancer Therapeutics Major Product Offerings
7.10.4 Teva Pharmaceutical Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.10.5 Teva Pharmaceutical Key News
7.11 Eli Lilly
7.11.1 Eli Lilly Corporate Summary
7.11.2 Eli Lilly Business Overview
7.11.3 Eli Lilly Small Cell Lung Cancer Therapeutics Major Product Offerings
7.11.4 Eli Lilly Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.11.5 Eli Lilly Key News
7.12 Mylan
7.12.1 Mylan Corporate Summary
7.12.2 Mylan Business Overview
7.12.3 Mylan Small Cell Lung Cancer Therapeutics Major Product Offerings
7.12.4 Mylan Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.12.5 Mylan Key News
7.13 Sun Pharmaceuticals Industries
7.13.1 Sun Pharmaceuticals Industries Corporate Summary
7.13.2 Sun Pharmaceuticals Industries Business Overview
7.13.3 Sun Pharmaceuticals Industries Small Cell Lung Cancer Therapeutics Major Product Offerings
7.13.4 Sun Pharmaceuticals Industries Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.13.5 Sun Pharmaceuticals Industries Key News
7.14 Amgen
7.14.1 Amgen Corporate Summary
7.14.2 Amgen Business Overview
7.14.3 Amgen Small Cell Lung Cancer Therapeutics Major Product Offerings
7.14.4 Amgen Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.14.5 Amgen Key News
7.15 Ono Pharmaceutical
7.15.1 Ono Pharmaceutical Corporate Summary
7.15.2 Ono Pharmaceutical Business Overview
7.15.3 Ono Pharmaceutical Small Cell Lung Cancer Therapeutics Major Product Offerings
7.15.4 Ono Pharmaceutical Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.15.5 Ono Pharmaceutical Key News
7.16 Shanghai Jinhe Bio-Technology
7.16.1 Shanghai Jinhe Bio-Technology Corporate Summary
7.16.2 Shanghai Jinhe Bio-Technology Business Overview
7.16.3 Shanghai Jinhe Bio-Technology Small Cell Lung Cancer Therapeutics Major Product Offerings
7.16.4 Shanghai Jinhe Bio-Technology Small Cell Lung Cancer Therapeutics Revenue in Global (2016-2021)
7.16.5 Shanghai Jinhe Bio-Technology Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Small Cell Lung Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Small Cell Lung Cancer Therapeutics Market Drivers in Global Market
Table 3. Small Cell Lung Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Small Cell Lung Cancer Therapeutics in Global Market
Table 5. Top Small Cell Lung Cancer Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Small Cell Lung Cancer Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Small Cell Lung Cancer Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Small Cell Lung Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Small Cell Lung Cancer Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Small Cell Lung Cancer Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Small Cell Lung Cancer Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Small Cell Lung Cancer Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Small Cell Lung Cancer Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Small Cell Lung Cancer Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Small Cell Lung Cancer Therapeutics Product Offerings
Table 32. Sanofi Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Small Cell Lung Cancer Therapeutics Product Offerings
Table 35. Bristol-Myers Squibb Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Small Cell Lung Cancer Therapeutics Product Offerings
Table 38. GlaxoSmithKline Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. Menarini Corporate Summary
Table 40. Menarini Small Cell Lung Cancer Therapeutics Product Offerings
Table 41. Menarini Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Ziopharm Oncology Corporate Summary
Table 43. Ziopharm Oncology Small Cell Lung Cancer Therapeutics Product Offerings
Table 44. Ziopharm Oncology Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Merck Corporate Summary
Table 46. Merck Small Cell Lung Cancer Therapeutics Product Offerings
Table 47. Merck Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. Novartis Corporate Summary
Table 49. Novartis Small Cell Lung Cancer Therapeutics Product Offerings
Table 50. Novartis Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. AstraZeneca Corporate Summary
Table 52. AstraZeneca Small Cell Lung Cancer Therapeutics Product Offerings
Table 53. AstraZeneca Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Takeda Pharmaceutical Corporate Summary
Table 55. Takeda Pharmaceutical Small Cell Lung Cancer Therapeutics Product Offerings
Table 56. Takeda Pharmaceutical Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. Teva Pharmaceutical Corporate Summary
Table 58. Teva Pharmaceutical Small Cell Lung Cancer Therapeutics Product Offerings
Table 59. Teva Pharmaceutical Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 60. Eli Lilly Corporate Summary
Table 61. Eli Lilly Small Cell Lung Cancer Therapeutics Product Offerings
Table 62. Eli Lilly Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 63. Mylan Corporate Summary
Table 64. Mylan Small Cell Lung Cancer Therapeutics Product Offerings
Table 65. Mylan Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 66. Sun Pharmaceuticals Industries Corporate Summary
Table 67. Sun Pharmaceuticals Industries Small Cell Lung Cancer Therapeutics Product Offerings
Table 68. Sun Pharmaceuticals Industries Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 69. Amgen Corporate Summary
Table 70. Amgen Small Cell Lung Cancer Therapeutics Product Offerings
Table 71. Amgen Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 72. Ono Pharmaceutical Corporate Summary
Table 73. Ono Pharmaceutical Small Cell Lung Cancer Therapeutics Product Offerings
Table 74. Ono Pharmaceutical Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
Table 75. Shanghai Jinhe Bio-Technology Corporate Summary
Table 76. Shanghai Jinhe Bio-Technology Small Cell Lung Cancer Therapeutics Product Offerings
Table 77. Shanghai Jinhe Bio-Technology Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Small Cell Lung Cancer Therapeutics Segment by Type
Figure 2. Small Cell Lung Cancer Therapeutics Segment by Application
Figure 3. Global Small Cell Lung Cancer Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Small Cell Lung Cancer Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Small Cell Lung Cancer Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Small Cell Lung Cancer Therapeutics Revenue in 2020
Figure 8. By Type - Global Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Small Cell Lung Cancer Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Sanofi Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Bristol-Myers Squibb Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. GlaxoSmithKline Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Menarini Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Ziopharm Oncology Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Merck Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Novartis Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. AstraZeneca Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Takeda Pharmaceutical Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Teva Pharmaceutical Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Eli Lilly Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Mylan Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Sun Pharmaceuticals Industries Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Amgen Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Ono Pharmaceutical Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Shanghai Jinhe Bio-Technology Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Sanofi
Bristol-Myers Squibb
GlaxoSmithKline
Menarini
Ziopharm Oncology
Merck
Novartis
AstraZeneca
Takeda Pharmaceutical
Teva Pharmaceutical
Eli Lilly
Mylan
Sun Pharmaceuticals Industries
Amgen
Ono Pharmaceutical
Shanghai Jinhe Bio-Technology